Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.4.3 was applied; no changes to the study details are evident.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous government-funding status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check65 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check72 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label capitalization and the 'No FEAR Act Data' notices.SummaryDifference0.2%

- Check87 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.